Lv52
1490 积分 2022-07-12 加入
Efficacy of a three day course of azithromycin in moderately severe community-acquired pneumonia
28天前
已完结
Comparison of the ameliorative effects of Qingfei Tongluo formula and azithromycin on Mycoplasma pneumoniae pneumonia
28天前
已完结
First-in-human randomized study of RNAi therapeutic RG6346 for chronic hepatitis B virus infection
1个月前
已完结
Pharmacokinetics of JNJ‐73763989 and JNJ‐56136379 (Bersacapavir) in Participants With Moderate Hepatic Impairment
1个月前
已完结
WED-388 Safety, tolerability, and hepatitis B surface antigen reduction of HT-101 in chronic hepatitis B patients: preliminary results from a phase I b study
1个月前
已完结
Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B
1个月前
已完结
Preliminary safety and antiviral activity of VIR-2218, an X-targeting HBV RNAi therapeutic, in chronic hepatitis B patients
1个月前
已完结
The impact of HBsAg reduction via siRNA treatment on natural and vaccine (BRII-179)-induced HBV-specific humoral and cellular immune responses
1个月前
已完结
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study
1个月前
已完结
Control of Hepatitis B Virus with Imdusiran, a Small Interfering RNA Therapeutic
1个月前
已完结
皖公网安备34019202002308
